Business

Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology

Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTract™ Safety Syringe, powered by SafeR® passive safety technology developed by Roncadelle Operations S.r.l. The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026.

articleTerumo CorporationJanuary 6, 20263/company/terumo-corporation/news/terumo-launches-surtracttm-safety-syringe-in-the-united-states-powered-by-roncadelle-operations-saferr-passive-safety-technology
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology

About this update from Terumo Corporation

[{"type":"text","content":"- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* -","length":137,"tagName":"p","attribs":{}},{"type":"text","content":"SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTract™ Safety Syringe, powered by SafeR® passive safety technology developed by Roncadelle Operations S.r.l. The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026.","length":400,"tagName":"p"},{"type":"text","content":"SafeR technology provides the SurTract Syringe with a fully passive, automatic retraction mechanism that withdraws the needle into the plunger immediately after use – helping reduce the risk of needle-stick injuries for physicians, and providing patients with a smooth and comfortable injection due to less plunger pressure*. The syringe system also preserves standard clinical technique while offering enhanced safety, reliability and ease of use.","length":448,"tagName":"p"},{"type":"text","content":"Other benefits include:","length":23,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"A customizable needle selection designed for use exclusively with SurTract Syringes, allowing physicians the opportunity to create the combination they need for optimal patient care.","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"A blunt needle, preventing dullness and allowing a change of needle for drawing up aspiration.","length":94,"tagName":"p"}]},{"val":[{"type":"text","content":"Less medical waste due to a lack of an external plastic safety sheath.","length":70,"tagName":"p"}]},{"val":[{"type":"text","content":"Reduction in medication waste due to the low dead space syringe*.","length":65,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":411,"olType":false},{"type":"text","content":""The SurTract Syringe combines Terumo's trusted clinical know-how with Roncadelle's validated SafeR technology to deliver a simple, effective solution for safer injections," said Bob Klock, Vice President, Terumo Medical Corporation. "It gives healthcare providers more – and better – treatment options for their patients, which is our ultima...

More updates from Terumo Corporation

TerumoTerumo Medical CorporationRoncadelleSafety Syringeinjection safety